Jiayi Tong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiayi Tong has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Yong Chen
The Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania Philadelphia Pennsylvania USA
3 shared publications - Cui Tao
Department of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL 32224, USA
2 shared publications - Jiang Bian
Indiana University
2 shared publications - Rui Duan
Department of Biostatistics, School of Public Health, Harvard University , Boston, MA, 02115
2 shared publications - Tianchen Lyu
University of Florida
2 shared publications - Zhaoyi Chen
University of Florida
2 shared publications
Latest Publications
- Open Access
OrigamiPlot: An R Package and Shiny Web App Enhanced Visualizations for Multivariate Data
We introduce OrigamiPlot, an open-source R package and Shiny web application designed to enhance the visualization of multivariate data. This package implements the origami plot, a novel visualization technique proposed by Duan et al. in 2023, which improves upon traditional radar charts by ensuring that the area of the connected region is invariant to the ordering of attributes, addressing a key limitation of radar charts. The software facilitates multivariate decision-making by supporting comparisons across multiple objects and attributes, offering customizable features such as auxiliary axes and weighted attributes for enhanced clarity. Through the R package and user-friendly Shiny interface, researchers can efficiently create and customize plots without requiring extensive programming knowledge. Demonstrated using network meta-analysis as a real-world example, OrigamiPlot proves to be a versatile tool for visualizing multivariate data across various fields. This package opens new opportunities for simplifying decision-making processes with complex data.
Open AccessOrigamiPlot: An R Package and Shiny Web App Enhanced Visualizations for Multivariate Data
We introduce OrigamiPlot, an open-source R package and Shiny web application designed to enhance the visualization of multivariate data. This package implements the origami plot, a novel visualization technique proposed by Duan et al. in 2023, which improves upon traditional radar charts by ensuring that the area of the connected region is invariant to the ordering of attributes, addressing a key limitation of radar charts. The software facilitates multivariate decision-making by supporting comparisons across multiple objects and attributes, offering customizable features such as auxiliary axes and weighted attributes for enhanced clarity. Through the R package and user-friendly Shiny interface, researchers can efficiently create and customize plots without requiring extensive programming knowledge. Demonstrated using network meta-analysis as a real-world example, OrigamiPlot proves to be a versatile tool for visualizing multivariate data across various fields. This package opens new opportunities for simplifying decision-making processes with complex data.
- Open Access
Exploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease
In this study, we explored the feasibility of using real-world data (RWD) from a large clinical research network to simulate real-world clinical trials of Alzheimer’s disease (AD). The target trial (i.e., NCT00478205 ) is a Phase III double-blind, parallel-group trial that compared the 23 mg donepezil sustained release with the 10 mg donepezil immediate release formulation in patients with moderate to severe AD. We followed the target trial’s study protocol to identify the study population, treatment regimen assignments, and outcome assessments, and to set up a number of different simulation scenarios and parameters. We considered two main scenarios: (1) a one-arm simulation: simulating a standard-of-care arm that can serve as an external control arm; and (2) a two-arm simulation: simulating both intervention and control arms with proper patient matching algorithms for comparative effectiveness analysis. In the two-arm simulation scenario, we used propensity score matching controlling for baseline characteristics to simulate the randomization process. In the two-arm simulation, higher SAE rates were observed in the simulated trials than the rates reported in original trial, and a higher SAE rate was observed in the 23mg arm than the 10 mg standard-of-care arm. In the one-arm simulation scenario, similar estimates of SAE rates were observed when proportional sampling was used to control demographic variables. In conclusion, trial simulation using RWD is feasible in this example of AD trial in terms of safety evaluation. Trial simulation using RWD could be a valuable tool for post-market comparative effectiveness studies and for informing future trials’ design. Nevertheless, such approach may be limited, for example, by the availability of RWD that matches the target trials of interest, and further investigations are warranted.
Open AccessExploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease
In this study, we explored the feasibility of using real-world data (RWD) from a large clinical research network to simulate real-world clinical trials of Alzheimer’s disease (AD). The target trial (i.e., NCT00478205 ) is a Phase III double-blind, parallel-group trial that compared the 23 mg donepezil sustained release with the 10 mg donepezil immediate release formulation in patients with moderate to severe AD. We followed the target trial’s study protocol to identify the study population, treatment regimen assignments, and outcome assessments, and to set up a number of different simulation scenarios and parameters. We considered two main scenarios: (1) a one-arm simulation: simulating a standard-of-care arm that can serve as an external control arm; and (2) a two-arm simulation: simulating both intervention and control arms with proper patient matching algorithms for comparative effectiveness analysis. In the two-arm simulation scenario, we used propensity score matching controlling for baseline characteristics to simulate the randomization process. In the two-arm simulation, higher SAE rates were observed in the simulated trials than the rates reported in original trial, and a higher SAE rate was observed in the 23mg arm than the 10 mg standard-of-care arm. In the one-arm simulation scenario, similar estimates of SAE rates were observed when proportional sampling was used to control demographic variables. In conclusion, trial simulation using RWD is feasible in this example of AD trial in terms of safety evaluation. Trial simulation using RWD could be a valuable tool for post-market comparative effectiveness studies and for informing future trials’ design. Nevertheless, such approach may be limited, for example, by the availability of RWD that matches the target trials of interest, and further investigations are warranted.
- Open Access
Leverage Real-world Longitudinal Data in Large Clinical Research Networks for Alzheimer’s Disease and Related Dementia (ADRD)
With vast amounts of patients’ medical information, electronic health records (EHRs) are becoming one of the most important data sources in biomedical and health care research. Effectively integrating data from multiple clinical sites can help provide more generalized real-world evidence that is clinically meaningful. To analyze the clinical data from multiple sites, distributed algorithms are developed to protect patient privacy without sharing individual-level medical information. In this paper, we applied the One-shot Distributed Algorithm for Cox proportional hazard model (ODAC) to the longitudinal data from the OneFlorida Clinical Research Consortium to demonstrate the feasibility of implementing the distributed algorithms in large research networks. We studied the associations between the clinical risk factors and Alzheimer’s disease and related dementia (ADRD) onsets to advance clinical research on our understanding of the complex risk factors of ADRD and ultimately improve the care of ADRD patients.
Open AccessLeverage Real-world Longitudinal Data in Large Clinical Research Networks for Alzheimer’s Disease and Related Dementia (ADRD)
With vast amounts of patients’ medical information, electronic health records (EHRs) are becoming one of the most important data sources in biomedical and health care research. Effectively integrating data from multiple clinical sites can help provide more generalized real-world evidence that is clinically meaningful. To analyze the clinical data from multiple sites, distributed algorithms are developed to protect patient privacy without sharing individual-level medical information. In this paper, we applied the One-shot Distributed Algorithm for Cox proportional hazard model (ODAC) to the longitudinal data from the OneFlorida Clinical Research Consortium to demonstrate the feasibility of implementing the distributed algorithms in large research networks. We studied the associations between the clinical risk factors and Alzheimer’s disease and related dementia (ADRD) onsets to advance clinical research on our understanding of the complex risk factors of ADRD and ultimately improve the care of ADRD patients.